EAM Investors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
EAM Investors's IRMD Position: Q2 2026 in Review
EAM Investors sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 49,995 shares — an estimated $4.81M sold.
EAM Investors first reported a position in IRMD in Q2 2015 and held it in 16 quarters. The position peaked at $5.36M in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- EAM Investors reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
- EAM Investors sold 49,995 iRadimed shares in Q2 2026, an estimated $4.81M.
- EAM Investors first reported a position in iRadimed in Q2 2015 and held it in 16 quarters.
- EAM Investors's iRadimed position peaked at $5.36M in Q4 2025.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.